This clinical quality registry aims to improve myeloma outcomes by providing an evidence base for the best strategies to diagnose, treat and support people with myeloma and related diseases.
Patients with multiple myeloma
Number of approved sites
MRDR-based FRAIL-M trial now has 10 sites & 10 patients recruited!Read more
$5.3 million funding over 5 years approved for APAC MRDRRead more